Freestyle Libre 2 Plus®
Clinical Indication
Diabetes Continuous glucose monitoring (CGM)
Comments
Freestyle Libre 2 Plus® is approved for use in LLR for diabetes glucose monitoring where a patient meets the criteria detailed in the LLR APC position statement.
Date of classification
July 2024
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .